Literature DB >> 28050693

Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis.

Giovanni Mauri1, Luca Maria Sconfienza2,3, Lorenzo Carlo Pescatori4, Maria Paola Fedeli4, Marco Alì5, Giovanni Di Leo6, Francesco Sardanelli2,6.   

Abstract

OBJECTIVES: To systematically review studies concerning imaging-guided minimally-invasive breast cancer treatments.
METHODS: An online database search was performed for English-language articles evaluating percutaneous breast cancer ablation. Pooled data and 95% confidence intervals (CIs) were calculated. Technical success, technique efficacy, minor and major complications were analysed, including ablation technique subgroup analysis and effect of tumour size on outcome.
RESULTS: Forty-five studies were analysed, including 1,156 patients and 1,168 lesions. Radiofrequency (n=577; 50%), microwaves (n=78; 7%), laser (n=227; 19%), cryoablation (n=156; 13%) and high-intensity focused ultrasound (HIFU, n=129; 11%) were used. Pooled technical success was 96% (95%CI 94-97%) [laser=98% (95-99%); HIFU=96% (90-98%); radiofrequency=96% (93-97%); cryoablation=95% (90-98%); microwave=93% (81-98%)]. Pooled technique efficacy was 75% (67-81%) [radiofrequency=82% (74-88); cryoablation=75% (51-90); laser=59% (35-79); HIFU=49% (26-74)]. Major complications pooled rate was 6% (4-8). Minor complications pooled rate was 8% (5-13%). Differences between techniques were not significant for technical success (p=0.449), major complications (p=0.181) or minor complications (p=0.762), but significant for technique efficacy (p=0.009). Tumour size did not impact on variables (p>0.142).
CONCLUSIONS: Imaging-guided percutaneous ablation techniques of breast cancer have a high rate of technical success, while technique efficacy remains suboptimal. Complication rates are relatively low. KEY POINTS: • Imaging-guided ablation techniques for breast cancer are 96% technically successful. • Overall technique efficacy rate is 75% but largely inhomogeneous among studies. • Overall major and minor complication rates are low (6-8%).

Entities:  

Keywords:  Breast cancer; Meta-analysis; Minimally-invasive treatment; Systematic review; Thermal ablation

Mesh:

Year:  2017        PMID: 28050693     DOI: 10.1007/s00330-016-4668-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  73 in total

1.  Surgical guidelines for the management of breast cancer.

Authors: 
Journal:  Eur J Surg Oncol       Date:  2009-03-18       Impact factor: 4.424

2.  Is breast cancer overdiagnosis also nested in pathologic misclassification?

Authors:  Catherine Colin; Mojgan Devouassoux-Shisheboran; Francesco Sardanelli
Journal:  Radiology       Date:  2014-12       Impact factor: 11.105

Review 3.  Margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology consensus guideline.

Authors:  Thomas A Buchholz; Mark R Somerfield; Jennifer J Griggs; Souzan El-Eid; M Elizabeth H Hammond; Gary H Lyman; Ginny Mason; Lisa A Newman
Journal:  J Clin Oncol       Date:  2014-04-07       Impact factor: 44.544

4.  Radiofrequency ablation of small breast cancer followed by surgical resection.

Authors:  Masakuni Noguchi; Mitsuharu Earashi; Hisatake Fujii; Koichi Yokoyama; Ken-ichi Harada; Koichi Tsuneyama
Journal:  J Surg Oncol       Date:  2006-02-01       Impact factor: 3.454

5.  Laser therapy for breast cancer: MR imaging and histopathologic correlation.

Authors:  H Mumtaz; M A Hall-Craggs; A Wotherspoon; M Paley; G Buonaccorsi; Z Amin; I Wilkinson; M W Kissin; T I Davidson; I Taylor; S G Bown
Journal:  Radiology       Date:  1996-09       Impact factor: 11.105

6.  Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma.

Authors:  David Gianfelice; Abdesslem Khiat; Yvan Boulanger; Mourad Amara; Assia Belblidia
Journal:  J Vasc Interv Radiol       Date:  2003-10       Impact factor: 3.464

7.  Predictors of surgical margin status in breast-conserving surgery within a breast screening program.

Authors:  Emil D Kurniawan; Matthew H Wong; Imogen Windle; Allison Rose; Arlene Mou; Malcolm Buchanan; John P Collins; Julie A Miller; Russell L Gruen; G Bruce Mann
Journal:  Ann Surg Oncol       Date:  2008-07-10       Impact factor: 5.344

8.  Cryotherapy for breast cancer: a feasibility study without excision.

Authors:  Peter J Littrup; Bassel Jallad; Priti Chandiwala-Mody; Monica D'Agostini; Barbara A Adam; David Bouwman
Journal:  J Vasc Interv Radiol       Date:  2009-10       Impact factor: 3.464

9.  Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process.

Authors:  Min-Hua Chen; Wei Yang; Kun Yan; Ming-Wu Zou; Luigi Solbiati; Ji-Bin Liu; Ying Dai
Journal:  Radiology       Date:  2004-05-27       Impact factor: 11.105

10.  A basic introduction to fixed-effect and random-effects models for meta-analysis.

Authors:  Michael Borenstein; Larry V Hedges; Julian P T Higgins; Hannah R Rothstein
Journal:  Res Synth Methods       Date:  2010-11-21       Impact factor: 5.273

View more
  19 in total

Review 1.  Focused ultrasound: tumour ablation and its potential to enhance immunological therapy to cancer.

Authors:  Giovanni Mauri; Luca Nicosia; Zhen Xu; Salvatore Di Pietro; Lorenzo Monfardini; Guido Bonomo; Gianluca Maria Varano; Francesco Prada; Paolo Della Vigna; Franco Orsi
Journal:  Br J Radiol       Date:  2018-01-17       Impact factor: 3.039

2.  Reporting bias in imaging: higher accuracy is linked to faster publication.

Authors:  A Dehmoobad Sharifabadi; D A Korevaar; T A McGrath; N van Es; R A Frank; L Cherpak; W Dang; J P Salameh; F Nguyen; C Stanley; M D F McInnes
Journal:  Eur Radiol       Date:  2018-03-21       Impact factor: 5.315

3.  Efficacy and Safety of Radiofrequency Ablation for Breast Cancer Smaller Than 2 cm: A Systematic Review and Meta-Analysis.

Authors:  Lin-Yu Xia; Qing-Lin Hu; Wei-Yun Xu
Journal:  Front Oncol       Date:  2021-05-03       Impact factor: 6.244

Review 4.  Tips and tricks for a safe and effective image-guided percutaneous renal tumour ablation.

Authors:  Giovanni Mauri; L Nicosia; G M Varano; G Bonomo; P Della Vigna; L Monfardini; F Orsi
Journal:  Insights Imaging       Date:  2017-05-12

Review 5.  High-intensity focused ultrasound in the treatment of breast tumours.

Authors:  Mirjam C L Peek; Feng Wu
Journal:  Ecancermedicalscience       Date:  2018-01-10

6.  Multifunctional Nanoparticles Encapsulating Astragalus Polysaccharide and Gold Nanorods in Combination with Focused Ultrasound for the Treatment of Breast Cancer.

Authors:  Jie Xiong; Binglei Jiang; Yong Luo; Jianzhong Zou; Xuan Gao; Die Xu; Yan Du; Lan Hao
Journal:  Int J Nanomedicine       Date:  2020-06-12

Review 7.  Radiofrequency ablation of osteoid osteoma.

Authors:  Massimo De Filippo; Umberto Russo; Vito Roberto Papapietro; Francesco Ceccarelli; Francesco Pogliacomi; Enrico Vaienti; Claudia Piccolo; Raffaella Capasso; Assunta Sica; Fabrizio Cioce; Mattia Carbone; Federico Bruno; Carlo Masciocchi; Vittorio Miele
Journal:  Acta Biomed       Date:  2018-01-19

8.  Ultrasound guided percutaneous microwave ablation of benign breast lesions.

Authors:  Jie Yu; Bao-Hua Chen; Jing Zhang; Zhi-Yu Han; Han Wu; Yan Huang; Meng-Juan Mu; Ping Liang
Journal:  Oncotarget       Date:  2017-05-23

9.  Cryoablation of Primary Breast Cancer in Patients with Metastatic Disease: Considerations Arising from a Single-Centre Data Analysis.

Authors:  Claudio Pusceddu; Luca Melis; Nicola Ballicu; Paolo Meloni; Valeria Sanna; Alberto Porcu; Alessandro Fancellu
Journal:  Biomed Res Int       Date:  2017-10-19       Impact factor: 3.411

10.  Augmented reality for interventional oncology: proof-of-concept study of a novel high-end guidance system platform.

Authors:  Marco Solbiati; Katia M Passera; Alessandro Rotilio; Francesco Oliva; Ilaria Marre; S Nahum Goldberg; Tiziana Ierace; Luigi Solbiati
Journal:  Eur Radiol Exp       Date:  2018-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.